Indian patent office rejects TB Alliance’s patent for Drug-Resistant TB treatment
The Indian Patent Office has rejected a patent application by the US-based Global Alliance for TB Drug Development (TB Alliance) for BPaL, a treatment for drug-resistant tuberculosis (TB). The order, dated October 27, came after two objections were filed by patient…